Alglucosidase alfa: 5 years of experience in late-onset Pompe disease

Ítems similars

• Enzyme replacement therapy with alglucosidase alfa in Pompe disease: Clinical experience with rate escalation
  per: Desai, Ankit K., et al.
  Publicat: (2017)
• The clinical relevance of outcomes used in late-onset Pompe disease: can we do better?
  per: Lachmann, Robin, et al.
  Publicat: (2013)
• ALGLUCOSIDASE ALFA — A NEW STAGE IN THE THERAPY OF INFANTILE POMPE DISEASE
  per: E. N. Basargina, et al.
  Publicat: (2014-09-01)
• Alglucosidase alfa: Long term use in the treatment of patients with Pompe disease
  per: Beck, Michael
  Publicat: (2009)
• Earlier and higher dosing of alglucosidase alfa improve outcomes in patients with infantile-onset Pompe disease: Evidence from real-world experiences
  per: Chien, Yin-Hsiu, et al.
  Publicat: (2020)